Semaglutide has more published data on inflammatory marker reduction
Ozempic, known generically as semaglutide, is a GLP-1 receptor agonist that supports blood sugar regulation by stimulating insulin secretion, reducing glucagon release, and slowing gastric emptying
Crucially, unlike apoptosis, which is typically immunologically silent, necroptosis results in cell lysis and the release of damage-associated molecular patterns, thereby provoking a potent inflammatory response (40)
This overexpression can subsequently elevate the levels of estradiol and prostaglandin E2 (PGE2), promoting inflammation and facilitating cell growth
At Regain Functional Wellness and Aesthetics, we want to help you understand the difference between GLP-1, GLP-2, and GLP-3 so you can feel informed about the treatment you are receiving